New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 11, 2012
11:25 EDTDKAM, DKAM, LTBR, LTBR, NBS, NBS, LQMT, LQMT, NVTL, NVTL, ASUR, ASUR, GALE, GALE, LLTC, LLTC, AEMD, AEMD, TAS, TAS, COPY, COPY, CDXC, CDXC, LLEN, LLEN, LPH, LPHRedChip Companies to host a conference
15th Annual Small-Cap Conference is being held in San Francisco on October 15 with webcasted company presentations to begin at 11:30 am. Webcast Link
News For LPH;LLEN;CDXC;COPY;TAS;AEMD;LLTC;GALE;ASUR;NVTL;LQMT;NBS;LTBR;DKAM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
14:08 EDTGALEGalena files to sell 2M shares of common stock for holders
Subscribe for More Information
October 20, 2014
07:35 EDTLTBRLightbridge signs initial cooperation agreement AECL
Subscribe for More Information
October 17, 2014
05:06 EDTLTBRLightbridge, Vietnam sign agreement for consulting support on nuclear research
Subscribe for More Information
October 16, 2014
10:01 EDTLLTCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:02 EDTLLTCLinear Technology upgraded to Hold from Cautious at ISI Group
Subscribe for More Information
October 15, 2014
10:49 EDTLLTCHigh option volume stocks
High option volume stocks: SNV FCG TXT MDSO PPHM NTRS CCL RGP LLTC SOCL
October 14, 2014
18:20 EDTLLTCOn The Fly: After Hours Movers
Subscribe for More Information
17:08 EDTLLTCLinear Technology sees Q2 revenue down 3%-6%
Subscribe for More Information
17:06 EDTLLTCLinear Technology reports Q1 EPS 53c, consensus 54c
Subscribe for More Information
17:01 EDTLLTCLinear Technology announces CFO transition plan
Subscribe for More Information
15:29 EDTLLTCNotable companies reporting after market close
Subscribe for More Information
13:17 EDTLLTCLinear Technology technical comments ahead of earnings
Subscribe for More Information
07:17 EDTGALEGalena receives notice of allowance of improvement patent for NeuVax in Japan
Galena Biopharma announced the notice of allowance from the Japanese Patent Office for NeuVax covering the use of NeuVax alone or in combination with other agents to prevent recurrence of any HER2/neu expressing breast cancer tumor having an immunohistochemistry level of 1+ or 2+, or a fluorescence in situ hybridization rating of less than about 2.0. NeuVax is a peptide immunotherapy for the prevention of cancer recurrence and is Galena's lead development agent in multiple ongoing and planned clinical trials. Once issued, the patent will expire in 2027, not including any patent term extensions.
07:16 EDTAEMDAethlon Medical announces first use of Hemopurifier therapy on Ebola patient
Subscribe for More Information
06:57 EDTLLTCLinear Technology price target lowered to $46 from $55 at Oppenheimer
Subscribe for More Information
06:05 EDTNBSBioLife Solutions biopreservation products used at Progenitor Cell Therapy
BioLife Solutions (BLFS) provided an update on use of the company's HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media by Progenitor Cell Therapy, or PCT, a wholly owned subsidiary of NeoStem (NBS) a leader in the emerging cellular therapy field.
October 8, 2014
07:09 EDTGALEGalena reports Notice of Allowance of U.S. patent application for NeuVax
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use